VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹267 Cr | ₹278 Cr | ₹301 Cr | ₹322 Cr | ₹350 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹267 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹301 Cr |
Mar2021 | ₹322 Cr |
Mar2020 | ₹350 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹267 Cr | -3.93 | |
Mar2023 | ₹278 Cr | -7.59 | |
Mar2022 | ₹301 Cr | -6.44 | |
Mar2021 | ₹322 Cr | -7.99 | |
Mar2020 | ₹350 Cr | - |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹396.8 Cr | 4% | -15.8% | -9.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,569.0 Cr | 2.8% | -7.5% | 2.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹146,318.0 Cr | -0.2% | -9.9% | 60.4% | Stock Analytics | |
CIPLA | ₹118,110.0 Cr | 4.4% | -0.6% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,926.0 Cr | 4.8% | -2.9% | 15.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,471.5 Cr | NA | -9.4% | -10.2% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 4% |
-15.8% |
-9.2% |
SENSEX | 1.4% |
-5.3% |
0.3% |
You may also like the below Video Courses